Skip to main content
. Author manuscript; available in PMC: 2015 Apr 23.
Published in final edited form as: Int J Geriatr Psychiatry. 2008 Jun;23(6):625–631. doi: 10.1002/gps.1951

Table 2.

Outcome variables over time (by group)

Measure Placebo Galantamine p-value for effect



Baseline
(n = 18)
Week 12
(n = 16)
Week 24
(n = 13)
Baseline
(n = 19)
Week 12
(n = 9)
Week 12
(n = 9)
group
effect
time
effect
group
*time effect
HDRS-24 30.3 (6.7) 12.3 (7.3) 11.9 (6.9) 26.4 (4.5) 11.0 (6.9) 6.1 (3.2) 0.187 <0.0001 0.575
RBANS
  IM 86.7 (16.2) 97.9 (12.8) 106.2 (10.8) 90.6 (15.6) 101.4 (11.0) 103.1 (9.2) 0.775 0.0002 0.453
  VIS 83.7 (18.2) 97.1 (17.2) 98.8 (13.5) 87.0 (19.6) 97.1 (21.6) 87.6 (18.5) 0.966 0.019 0.219
  Language 87.9 (13.1) 94.6 (4.7) 96.4 (6.8) 95.1 (10.0) 97.4 (7.0) 96.0 (7.5) 0.020 0.011 0.159
  Attention 84.6 (20.5) 95.3 (13.5) 96.6 (15.5) 94.3 (18.2) 94.1 (17.8) 94.3 (16.1) 0.620 0.033 0.167
  DLmem 86.7 (14.2) 99.6 (13.8) 107.5 (13.9) 98.7 (10.4) 104.4 (12.7) 107.0 (12.2) 0.028 <0.0001 0.090
  Tsotal 81.6 (14.6) 95.3 (10.9) 101.2 (12.9) 90.9 (16.5) 98.9 (15.3) 96.3 (13.1) 0.226 0.0001 0.084

Dlmem = Delayed Memory; HDRS-24 = 24-item Hamilton Depression Rating Scale; IM = Immediate Memory; RBANS = Repeatable Battery for Neuropsychological Status; VIS = Visuospatial/Construction.